There is emerging evidence that link microRNAs as mediators of metabolic diseases including obesity and insulin resistance, as these can regulate multiple cellular pathways such as insulin signaling and adipogenesis [9]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.